Giuseppe Caruso, Gynecology Oncology Specialist at European Institute of Oncology, shared a post a post on LinkedIn:
“Two absolute giants on the stage, two highly inspiring women, Prof. Kathleen Moore and Prof. Nicoletta Colombo, at FOLight abbvie talking about mirvetuximab in platinum-resistant ovarian cancer.
Amazing to hear directly from the people who led the trials that made this treatment a reality.”
Other articles featuring Giuseppe Caruso on OncoDaily.
